Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects children and adults, and can lead to kidney failure.
Sparsentan may be a new treatment option for focal segmental glomerulosclerosis
- Post author:
- Post published:
- Post category:uncategorized